Are risk indices derived from CGM interchangeable with SMBG-Based indices?
Open accessAbstract
BACKGROUND: The risk of hypo- and hyperglycemia has been assessed for years by computing the well-known low blood glucose index (LBGI) and high blood glucose index (HBGI) on sparse self-monitoring blood glucose (SMBG) readings. These metrics have been shown to be predictive of future glycemic events and clinically relevant cutoff values to classify the state of a patient have been defined, but their application to continuous glucose monitoring (CGM) profiles has not been validated yet. The aim of this article is to explore the relationship between CGM-based and SMBG-based LBGI/HBGI, and provide a guideline to follow when these indices are computed on CGM time series. METHODS: Twenty-eight subjects with type 1 diabetes mellitus (T1DM) were monitored in daily-life conditions for up to 4 weeks with both SMBG and CGM systems. Linear and nonlinear models were considered to describe the relationship between risk indices evaluated on SMBG and CGM data. RESULTS: LBGI values obtained from CGM did not match closely SMBG-based values, with clear underestimation especially in the low risk range, and a linear transformation performed best to match CGM-based LBGI to SMBG-based LBGI. For HBGI, a linear model with unitary slope and no intercept was reliable, suggesting that no correction is needed to compute this index from CGM time series. CONCLUSIONS: Alternate versions of LBGI and HBGI adapted to the characteristics of CGM signals have been proposed that enable extending results obtained for SMBG data and using clinically relevant cutoff values previously defined to promptly classify the glycemic condition of a patient.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The performance of the NN-based bolus calculator was assessed on an independent test set generated by the UVa/Padova T1D Simulator.
“The performance of the NN-based BC was assessed on an independent test set generated by the UVa/Padova T1D Simulator in terms of blood glucose risk index (BGRI) [39], i.e., a popular metric of glycemic control that, thanks to symmetrisation of the glucose scale, is equally sensitive to hypoglycemia and hyperglycemia.”
From Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors (2020) · cites this paper as [39]
The citation lists haven’t been fetched yet
References 16 · Cited by 52
- Authors
- Fabris, C., Patek, S. D., & Breton, M. D.
- Affiliations
- University of Padua (IT)
- University of Virginia (US)
- Corresponding author
- Breton, Marc D.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2015-08-14
- Volume
- 10
- Issue
- 1
- Pages
- 50-59
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC4738215
- OpenAlex
- W2269003205
- Cited by
- 52
- References
- 16
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 8 · 2020: 9 · 2019: 8 · 2018: 6 · 2017: 4 · 2016: 2
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk051562-23)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-051562)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, self-monitoring of blood glucose, low blood glucose index, type 1 diabetes, hypoglycemia, hyperglycemia, linear operators
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Insulin Infusion Systems, Male, Middle Aged, Risk, Blood Glucose Self-Monitoring, Infusion Pumps, Implantable
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review